PROZINC- protamine zinc recombinant human insulin injection United States - English - NLM (National Library of Medicine)

prozinc- protamine zinc recombinant human insulin injection

boehringer ingelheim animal health usa inc. - insulin human (unii: 1y17cti5sr) (insulin human - unii:1y17cti5sr) - insulin human 40 [iu] in 1 ml - prozinc is contraindicated in cats sensitive to protamine zinc recombinant human insulin or any other ingredients in prozinc. prozinc is contraindicated during episodes of hypoglycemia. prozinc is contraindicated in dogs sensitive to protamine zinc recombinant human insulin or any other ingredients in prozinc. prozinc is contraindicated during episodes of hypoglycemia.

PREVICOX- firocoxib tablet, chewable United States - English - NLM (National Library of Medicine)

previcox- firocoxib tablet, chewable

boehringer ingelheim animal health usa inc - firocoxib (unii: y6v2w4s4wt) (firocoxib - unii:y6v2w4s4wt) - indications: previcox (firocoxib) chewable tablets are indicated for the control of pain and inflammation associated with osteoarthritis and for the control of postoperative pain and inflammation associated with soft-tissue and orthopedic surgery in dogs. contraindications: dogs with known hypersensitivity to firocoxib should not receive previcox.

CENTRAGARD- eprinomectin and praziquantel solution United States - English - NLM (National Library of Medicine)

centragard- eprinomectin and praziquantel solution

boehringer ingelheim animal health usa inc. - eprinomectin (unii: 75kp30fd8o) (eprinomectin - unii:75kp30fd8o), praziquantel (unii: 6490c9u457) (praziquantel - unii:6490c9u457) - centragard is indicated for the prevention of heartworm disease caused by dirofilaria immitis , and for the treatment and control of roundworms (adult and fourth stage larval toxocara cati ), hookworms (adult and fourth stage larval ancylostoma tubaeforme ; adult ancylostoma braziliense ), and tapeworms (adult dipylidium caninum and echinococcus multilocularis ) in cats and kittens 7 weeks of age and older and 1.8 lbs or greater.

LEGEND- hyaluronate sodium injection, solution United States - English - NLM (National Library of Medicine)

legend- hyaluronate sodium injection, solution

boehringer ingelheim animal health usa inc. - hyaluronate sodium (unii: yse9ppt4th) (hyaluronic acid - unii:s270n0trqy) - indications: legend injectable solution is indicated in the treatment of joint dysfunction of the carpus or fetlock in horses due to non-infectious synovitis associated with equine osteoarthritis. contraindications: there are no known contraindications for the use of legend solution in horses.

LEGEND- hyaluronate sodium injection, solution United States - English - NLM (National Library of Medicine)

legend- hyaluronate sodium injection, solution

boehringer ingelheim animal health usa inc - hyaluronate sodium (unii: yse9ppt4th) (hyaluronic acid - unii:s270n0trqy) - indications: legend injectable solution is indicated in the treatment of joint dysfunction of the carpus or fetlock in horses due to non-infectious synovitis associated with equine osteoarthritis. contraindications: there are no known contraindications for the use of legend solution in horses.

Mamyzin New Zealand - English - Ministry for Primary Industries

mamyzin

boehringer ingelheim animal health new zealand limited - penethamate hydriodide - penethamate hydriodide 955 g/kg - antibiotic

VETMEDIN- pimobendan tablet, chewable United States - English - NLM (National Library of Medicine)

vetmedin- pimobendan tablet, chewable

boehringer ingelheim animal health usa inc. - pimobendan (unii: 34ap3bbp9t) (pimobendan - unii:34ap3bbp9t) - pimobendan 1.25 mg - vetmedin (pimobendan) is indicated for the management of the signs of mild, moderate, or severe congestive heart failure in dogs due to clinical myxomatous mitral valve disease (mmvd) or dilated cardiomyopathy (dcm). vetmedin is indicated for use with concurrent therapy for congestive heart failure (e.g.,furosemide, etc.) as appropriate on a case-by-case basis. vetmedin should not be given in cases of hypertrophic cardiomyopathy, aortic stenosis, or any other clinical condition where an augmentation of cardiac output is inappropriate for functional or anatomical reasons. user safety warnings: not for use in humans. keep this and all medications out of reach of children. consult a physician in case of accidental ingestion by humans. animal safety warnings: keep vetmedin in a secure location out of reach of dogs, cats, and other animals to prevent accidental ingestion or overdose. only for use in dogs with clinical evidence of heart failure. at 3 and 5 times the recommended dosage, administered over a 6-month

SURPASS- diclofenac sodium cream United States - English - NLM (National Library of Medicine)

surpass- diclofenac sodium cream

boehringer ingelheim animal health usa inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 0.01 g in 1 g - surpass topical cream is indicated for the control of pain and inflammation associated with osteoarthritis (oa) in tarsal, carpal, metacarpophalangeal, metatarsophalangeal and proximal interphalangeal (hock, knee, fetlock and pastern) joints in horses. surpass topical cream is contraindicated in animals with known hypersensitivity to diclofenac.

METACAM- meloxicam injection, solution United States - English - NLM (National Library of Medicine)

metacam- meloxicam injection, solution

boehringer ingelheim animal health usa inc. - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam 5 mg in 1 ml - dogs: metacam injection is indicated in dogs for the control of pain and inflammation associated with osteoarthritis. dogs with known hypersensitivity to meloxicam should not receive metacam injection. cats: for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery. cats with known hypersensitivity to meloxicam should not receive metacam injection. additional doses of meloxicam or other nsaids in cats are contraindicated, as no safe dosage for repeated nsaid administration has been established (see animal safety). do not use meloxicam in cats with pre-existing renal dysfunction.

DISAL- furosemide tablet United States - English - NLM (National Library of Medicine)

disal- furosemide tablet

boehringer ingelheim animal health usa inc. - furosemide (unii: 7lxu5n7zo5) (furosemide - unii:7lxu5n7zo5) - furosemide 12.5 mg - dogs - disal tablets are indicated for the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute non-inflammatory tissue edema. in cases of edema involving cardiac insufficiency, the continued use of heart stimulants such as digitalis or its glycosides is indicated. the rationale for efficacious use of diuretic therapy is determined by the clinical pathology producing the edema. animal reproductive studies have shown that furosemide may cause fetal abnormality and the drug is contraindicated in pregnant animals. furosemide is contraindicated in anuria, furosemide hypersensitivity, hepatic coma, or during electrolytic imbalances. monitor serum electrolytes, bun and co2 frequently. monitor serum potassium levels and watch for signs of hypocalcemia. corticosteroids cause an additive potassium-depletion effect.